Home / Europe / Austria / Life Sciences & Healthcare

Life Sciences & Healthcare Law Firm in Austria

Law firm for Life Sciences & Healthcare in Austria 

The legal issues in health care law—such as those arising from e-health solutions, personalised medicine or cost-cutting restructuring—are increasing in complexity and require the coordination of a variety of specialist areas. Our experts have diverse professional backgrounds and combine specialist know-how with many years of experience in the industry. For example, we assist hospitals, outpatient clinics and group practices to draft contracts for healthcare professionals, also  for operational management of hospitals ("kollegiale Führung"). In addition, we have gained in-depth knowledge about the applicable regulatory requirements from advising pharmaceutical, medical device and biotechnology companies, hospitals and pharmacies, as well as universities and interest groups

We are available to advise you on numerous issues, including:

•    Drafting strategic agreements,
•    Planning a corporate transaction,
•    Employment of healthcare professionals,
•    Implementing compliance requirements, and
•    Enforcement and defence of claims in court.

A strong international network in the Life Sciences & Healthcare field:

The CMS Life Sciences & Healthcare Sector Group consists of a team of over 480 lawyers, patent attorneys, scientists and academics from all over the world. Our clients include the 20 leading global pharmaceutical companies and the 10 leading global medical device companies. Many of our experts worked in the Life Sciences & Healthcare sector before joining CMS and have extensive knowledge of the industry.

Our legal advice in the healthcare sector

We advise our clients in the following specific areas:

•    Pharmaceutical law
•    Medical device law
•    Hospital and pharmacy law
•    Medical professional law
•    Preclinical and clinical studies

•    Reimbursement / market access
•    Licensing, research and development collaborations
•    Advertising and marketing
•    Antitrust and distribution law
•    Anti-corruption criminal law and compliance
•    Data protection
•    Patent, trademark, design and copyright law, protection certificates
•    Customs procedures, product piracy and parallel imports
•    Product liability law
•    Dispute resolution
•    Corporate law, M&A and financing
•    Tax law
•    Labour Law
•    Social security law
•    Contract partner law
•    Public procurement law
•    Plant protection
•    Narcotics law
•    Food Law

Stay up to date

Would you like to receive regular information from us? Sign up for our newsletter (in German) and receive useful information on events or other important legal developments by e-mail.

Get to know our lawyers for Life Sciences & Healthcare here.

Calling the team "pragmatic and hands-on," a client extols its broad expertise and commercial understanding: "What I like about working with CMS is the fact that they can cover a wide range of legal topics when there are overlaps with other areas."

Chambers Europe 2022

Another client emphasises the law firm's client service: "I would particularly like to emphasise that the CMS team is always available for all of my concerns. I was not used to the fast response times and great commitment from my previous legal advisers and I do not want to do without CMS from now on. Based on my experience so far, I am convinced that the team will also support me in future to my absolute satisfaction."

Chambers Europe 2022

Choose area

Medical Law
Medical professional & labour law as key elements of the healthcare industry. Medical professional law and labour or service law play a central ro


Cannabis law and legislation in Austria
Medical use According to the Addictive Drugs Act, only the Austrian Agency for Health and Food Safety (AGES; supervised by the Austrian Federal Ministry of Labour, Social Affairs, Health and Consumer...
Patentability of inventions relating to diagnostic methods at the EPO
Under Article 53(c) of the European Patent Convention (EPC), diagnostic methods practised on the human or animal body are excluded from patentability. The purpose behind this exclusion is to avoid patent...
What’s in a name? Updated EMA guideline on naming medicinal products processed...
The updated EMA Guideline on the acceptability of names for human medicinal products processed through the centralised procedure was adopted by CHMP in December 2023 and came into effect on 1 January...
Adapting to the new EU Data Act: implications for medical devices and other...
In recent years, the European Commission developed a European data strategy, which aims to create a single European market in which data can circulate freely. As the European Commission has emphasized...
Digital health apps and telemedicine in Austria
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device” or a “product”...
COP28: Global Health Under the Spotlight
Health took centre stage at the first ever ‘Health Day’ at COP28 on 3 December. The program focused the attention of world leaders on the profound public health-related issues stemming from climate...
CMS Life Sciences Vital Signs, Winter 2023
2023 has seen some significant legal developments impacting the life sciences industry, and as we look ahead to 2024, there are several important developments which we would like to keep our clients informed...
Comprehensive guidance for AI businesses
Navigating the EU Artificial Intelligence Act & AI law related topics
EP Case Law in Brief: Erroneous Disclosures
“Mistakes in a document do not in themselves constitute prior art such as to prevent the grant of a patent.”So begins section I.C. 4.9 of the Case Law of the Boards of Appeal. This statement, and...
AI in healthcare inventions – technical or not technical?
SummaryRecent European Patent Office (EPO) Board of Appeal case T 1910/20 sits among a number of decisions regarding the discussion of what constitutes technical character in the field of healthcare...
UK announces £21m AI roll-out across NHS
IntroductionOn 23 June 2023, the UK government announced a £21 million fund aimed at accelerating the deployment of Artificial Intelligence (“AI”) across the National Health Service (“NHS”)...
CMS updates Global Expert Guide to Digital health apps and telemedicine
Digitisation is advancing steadily. Its pioneering innovations challenge all parties involved.One of the most important aspects in this area is the huge potential that lies in the digitisation of healthcare.In...